Barbara Gatto
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Insights into the complexity of SARS-CoV-2 Mpro inhibition: Ebselen and its derivatives impair dimerisation of the enzyme.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: January 02, 2026
The main protease (Mpro) from SARS-CoV-2 triggers plasma clotting in vitro by activating coagulation factors VII and FXII.
Journal: Communications biology
Published: October 17, 2024
Allostery in homodimeric SARS-CoV-2 main protease.
Journal: Communications biology
Published: July 25, 2024
Secondary 3-Chloropiperidines: Powerful Alkylating Agents.
Journal: ChemistryOpen
Published: September 21, 2023
In Vitro Chemical Mapping of G-Quadruplex DNA Structures by Bis-3-Chloropiperidines.
Journal: Journal of visualized experiments : JoVE
Published: May 29, 2023
Multifaceted Aspects of HIV-1 Nucleocapsid Inhibition by TAR-Targeting Peptidyl-Anthraquinones Bearing Terminal Aromatic Moieties.
Journal: Viruses
Published: September 13, 2022
In Vitro Evaluation of Bis-3-Chloropiperidines as RNA Modulators Targeting TAR and TAR-Protein Interaction.
Journal: International journal of molecular sciences
Published: December 12, 2021
A new inactive conformation of SARS-CoV-2 main protease.
Journal: Acta crystallographica. Section D, Structural biology
Published: November 17, 2021
Computationally driven discovery of SARS-CoV-2 Mpro inhibitors: from design to experimental validation.
Journal: Chemical science
Published: October 25, 2021
Bis-3-Chloropiperidines Targeting TAR RNA as A Novel Strategy to Impair the HIV-1 Nucleocapsid Protein.
Journal: Molecules (Basel, Switzerland)
Published: February 26, 2021
B-CePs as cross-linking probes for the investigation of RNA higher-order structure.
Journal: Nucleic acids research
Published: January 04, 2021
Last Updated: 09/26/2026